Skip to main content
Heliyon logoLink to Heliyon
. 2023 Aug 2;9(8):e18877. doi: 10.1016/j.heliyon.2023.e18877

Retraction notice to “In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions” [Heliyon 8, 2022 Article e10101]

Mustapha Abdullahi a,b,, Adamu Uzairu a, Gideon Adamu Shallangwa a, Paul Andrew Mamza a, Muhammad Tukur Ibrahim a
PMCID: PMC10493487  PMID: 37701398

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal).

This article has been retracted at the request of the Editor-in-Chief.

The paper uses the Molecular Operating Environment software. However the journal was informed by the software owner that the authors did not have a proper license to use it. The authors have been approached to retroactively solve this problem but were unable reach an agreement with the owner of the intellectual property.

As such, this represents a misuse of the scientific publishing system.

The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES